Skip to main content
FinSpry Logo
FinSpry
TNGX logo
TNGX
(NASDAQ)
Tango Therapeutics, Inc.
$22.52-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Tango Therapeutics (TNGX) Stock Price & Financial Analysis

Tango Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$22.29 - $22.94
52-Week High$34.39
52-Week Low$6.25
Open$22.48
Volume1.46M
Average Volume (3M)2.19M
Market Cap3.23B
Shares Outstanding143.58M
Price to Sales (P/S)56.73
Price to Book (P/B)8.26
EV/EBITDA-28.49
Revenue (TTM)56.99M
Net Income (TTM)-107.23M
Free Cash Flow (TTM)-142.54M
EPS (TTM)$-0.88
Profit Margin-188.15%
Operating Margin-206.22%
Return on Equity (ROE)-27.39%
Debt to Equity0.08
50-Day MA$27.09
200-Day MA$19.60
52-Week Change224.50%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Tango Therapeutics

What is the current stock price for TNGX?

As of the latest trading session, TNGX stock trades at $22.52. The 52-week range is $6.25–$34.39, with a day range of $22.29–$22.94.

What is the P/E ratio for TNGX?

The P/E ratio (Price-to-Earnings) for TNGX is shown in the Key Statistics section. This valuation metric helps compare Tango Therapeutics, Inc. to industry peers.

Does TNGX pay dividends?

Tango Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TNGX?

Based on 5 analysts, the consensus for TNGX is Buy.

What is the market cap of TNGX?

Tango Therapeutics's market capitalization is $3.23B, classifying it as a mid-cap company. Tango Therapeutics operates in the Healthcare sector within the Biotechnology industry.